查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1560019

自動細胞計數器市場報告：2030 年趨勢、預測與競爭分析

Automated Cell Counter Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

自動細胞計數器趨勢和預測

到 2030 年，全球自動細胞計數器市場預計將達到 172 億美元，2024 年至 2030 年複合年成長率為 6.5%。該市場的關鍵促進因素是癌症、愛滋病毒和糖尿病等慢性疾病的高盛行率，以及藥物研發投資的增加。全球自動細胞計數器市場的未來前景廣闊，醫院、實驗室和診斷中心市場充滿機會。

  • Lucintel 預計在預測期內實現最高成長，因為光強度價格實惠、易於使用，並被認為是醫院、實驗室和食品和飲料公司等各種環境中細胞計數的理想選擇。 。
  • 由於交通便利、先進的治療設施和高效的醫務人員以及不斷增加的患者數量，預計醫院仍將是該市場的最大細分市場。
  • 由於毒理學檢測產品和精準藥物的需求增加以及研發活動投資的增加，預計亞太地區在預測期內將出現最高成長。

自動細胞計數儀市場新趨勢

自動細胞計數器市場呈現各種新興趨勢，這些趨勢不僅重塑了產業，也推動了技術創新。

  • 人工智慧和機器學習的整合：人工智慧和機器學習被整合到自動細胞計數器中，以提高準確性和自動化資料分析。這改善了困難樣本的處理並實現更精細的細胞計數。
  • 設備小型化：小型、便攜、節省空間的自動細胞計數儀的趨勢正在增強。其應用範圍從小型實驗室到現場研究。
  • 高效能篩檢：高性能自動細胞計數器正在開發中，以實現更快、更大容量的處理。這一趨勢非常重要，特別是在大批量研究和臨床試驗中。
  • 成像技術：高解析度相機和螢光顯微鏡被認為是提高細胞計數品質的一些新成像技術。這樣可以獲得更高解析度和更準確的資料。
  • 具有成本效益的解決方案：隨著小型實驗室和研究機構對低成本、合適的自動細胞計數感興趣，該市場正在進一步擴大和採用。

由於技術、可近性和分析的快速發展，這些趨勢正在改變自動細胞計數器的市場模式。

自動細胞計數器市場的最新趨勢

自動細胞計數器市場的最新發展表明技術和應用方面取得了重大進展。

  • 人工智慧的整合：將人工智慧引入自動細胞計數中，提高了細胞計數的準確性和資料分析。人工智慧演算法現在可以更好地處理如此複雜的樣本，最大限度地減少人為錯誤。
  • 更小的型號：針對自動細胞計數器推出了一種新的更小的型號，具有便攜性和易用性。這些模型用於小型實驗室和行動研究應用。
  • 高性能系統：不斷開發領先的高性能細胞計數器，以非常高的速度處理大量樣本。這種類型的細胞計數器在高性能臨床和研究應用中也很重要。
  • 成像：現代細胞計數器採用先進的顯微鏡技術，例如高解析度和螢光。這些增強功能可以對細胞樣本進行詳細分析，同時提高視覺化效果。
  • 經濟實惠的解決方案：市場上經濟實惠的自動細胞計數器激增。這些經濟實惠的解決方案使我們能夠將先進的細胞計數技術帶給更多用戶。

這些因素對容量、可訪問性和滿足更多用戶的需求產生積極影響，為自動細胞計數器市場做出貢獻。

自動細胞計數器市場的策略性成長機會

自動細胞計數器市場在幾個關鍵應用中具有策略成長機會。

  • 臨床診斷：臨床診斷：臨床診斷中對高效細胞計數的需求不斷成長，從而開闢了成長途徑。擴大產品範圍以適應臨床細分市場將增加市場佔有率。
  • 研究機構：基因組學和藥物發現研究活動的成長為高性能、先進的自動化細胞計數帶來了機會。因此，對這些應用程式的投資可能會成為市場驅動力。
  • 照護現場：用於照護現場檢測的可攜式、方便用戶使用的細胞計數器的開發提供了更多的機會。這些儀器滿足遠端位置和小規模測試環境的需求。
  • 再生醫學：再生醫學和幹細胞研究的出現將增加對專用自動細胞計數器的需求。瞄準這一利基市場提供了巨大的成長潛力。
  • 教育和培訓：該細分市場也是一個不斷成長的細分市場，各種學術和培訓計劃正在增加對自動細胞計數器的需求。現在可以利用這一新興領域的可訪問的教學模型。

這些新機會預計將透過擴大應用、技術創新和新的客戶群來繼續塑造自動化細胞計數器市場。

自動化細胞計數器市場推廣因素及挑戰

影響自動細胞計數器市場成長和開拓的促進因素和挑戰有很多。主要列舉如下：

推動自動細胞計數器市場的因素如下：

1. 技術進步：這延伸到人工智慧、成像和自動化。這些領域的技術創新正在提高細胞計數器的準確性和效率，從而刺激市場。這些進步與研究和臨床應用的需求不斷成長同時出現。

2.研究和臨床需求的增加：研究和診斷需求的增加包括研究和診斷中對精確細胞計數的需求不斷增加，推動了市場成長。此外，大規模研究和診斷業務需要最先進的高通量細胞計數器。

3.醫療和研究基礎設施的擴展和發展：由於醫療和研究機構基礎設施的巨大發展，特別是在新興市場，自動細胞計數儀的數量正在增加。這為這個市場開闢了新的前景。

4.日益關注個人化醫療：隨著對個人化醫療的日益重視，對準確的細胞分析和細胞數的要求越來越高。自動細胞計數器在個人化治療方法的開發和分配中發揮關鍵作用。

5. 節省成本的措施：生產具有成本效益的自動細胞計數器使原本無法接觸到新技術的最終用戶能夠接觸到新技術，從而透過擴大不同的客戶群來刺激整體市場的成長。

自動細胞計數器市場問題如下。

1.初始成本高：先進的自動細胞計數儀的高價格可能會因其高成本而阻礙其廣泛採用，使得小型實驗室和研究機構難以負擔。為了進一步擴大市場，必須解決負擔能力問題。

2. 監管挑戰：新技術可能受到各種監管要求的約束，因此駕馭它們通常是複雜且耗時的。市場准入和產品認證必須遵守法規。

3.市場競爭：製造商之間的競爭激烈，影響市場佔有率和價格。為了增加競爭，公司需要創新並使其產品與眾不同。

這些市場促進因素/挑戰影響技術進步、市場動態和監管合規性，從而塑造自動細胞計數器市場。利用這些成長機會並克服市場障礙將取決於如何有效地解決這些因素。

自動分段細胞計數器

這項研究包括按類型、最終用途和地區對全球自動細胞計數儀進行預測。

各國自動細胞計數器市場前景

自動細胞計數器市場正在迅速開拓，只有透過技術變革和更高的細胞精度才能實現進步。近年來，美國、中國、德國、印度和日本都在提高細胞計數技術的準確性、速度和簡單性方面尋求創新。

  • 美國：隨著美國市場的快速成長，先進的自動化細胞計數器擴大配備人工智慧和機器學習功能。此類技術將進一步提高細胞分析的準確性和效率，滿足進階研究和臨床需求。
  • 中國：中國正大力投資經濟型自動細胞計數器的研發和製造。其重點是為更廣泛的實驗室和研究機構提供先進的細胞計數方法。
  • 德國：該國在提供高通量自動化細胞計數器方面處於領先地位。此外，創新也以與資料分析相關的先進軟體和可以在臨床和研究裝置中的大樣本量下運作的強大機器的形式發生。
  • 印度：印度市場在診斷和研究實驗室中安裝自動細胞計數器的情況增加。廉價且易於操作的模型越來越受歡迎，提高了診斷準確性並減輕了研究工作的壓力。
  • 日本：日本也在小幅推動自動細胞計數器的發展，其精密設計的模型具有高解析度影像和即時資料分析功能。這種研究和發展既對應於學術研究，也對應於臨床診斷。

常問問題

Q1.市場規模有多大？

答：到 2030 年，全球自動細胞計數器市場預計將達到 172 億美元。

Q2.市場成長預測如何？

答：2024年至2030年，全球自動細胞計數器市場預計將以6.5%的複合年成長率成長。

Q3.影響市場成長的關鍵促進因素有哪些？

答：該市場的關鍵促進因素是癌症、愛滋病毒和糖尿病等慢性病的高盛行率以及對藥品研發投資的增加。

Q4.市場的主要細分市場有哪些？

答：全球自動細胞計數儀市場前景廣闊，醫院、實驗室和診斷中心市場充滿機會。

Q5.市場上主要企業有哪些？

答：自動細胞計數器的主要企業如下。

  • Danaher
  • Thermo Fisher Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Sysmex Corporation
  • Beckman Coulter
  • HORIBA Medical
  • Mindray Medical International
  • Nihon Kohden
  • F. Hoffmann-La Roche

Q6.未來最大的細分市場是什麼？

答：Lucintel 預計光強度將在預測期內成為最高的產品之一，因為它們價格實惠、易於使用，並被認為是醫院、實驗室、食品和飲料公司等各種環境中細胞計數的理想選擇。

Q7. 未來五年預計哪個地區的市場最大？

答：由於毒理學檢測產品和精準藥物的需求不斷成長以及研發活動投資的增加，預計亞太地區在預測期內將出現最高成長。

Q8. 可以客製化報告嗎？

答：是的，Lucintel 列出了 10% 的客製化服務，無需額外費用。

目錄

第1章執行摘要

第2章全球自動細胞計數儀市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球自動細胞計數器市場趨勢（2018-2023）與預測（2024-2030）
  • 按類型分類的全球自動細胞計數器市場
    • 血球計數器
    • 流式細胞儀
    • 電電阻庫爾計數器
    • 光強度
  • 按最終用途分類的全球自動細胞計數器市場
    • 醫院
    • 研究所
    • 診斷中心
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球自動細胞計數儀市場（按地區）
  • 北美自動細胞計數器市場
  • 歐洲自動細胞計數器市場
  • 亞太自動細胞計數器市場
  • 其他地區自動細胞計數儀市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按類型分類的全球自動細胞計數器市場成長機會
    • 全球自動細胞計數器市場成長機會（依最終用途）
    • 按地區分類的全球自動細胞計數器市場成長機會
  • 全球自動細胞計數儀市場新趨勢
  • 戰略分析
    • 新產品開發
    • 全球自動細胞計數器市場的產能擴張
    • 全球自動化細胞計數器市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Danaher
  • Thermo Fisher Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Sysmex Corporation
  • Beckman Coulter
  • HORIBA Medical
  • Mindray Medical International
  • Nihon Kohden
  • F. Hoffmann-La Roche
簡介目錄

Automated Cell Counters Trends and Forecast

The future of the global automated cell counter market looks promising with opportunities in the hospital, research laboratory, and diagnostic center markets. The global automated cell counter market is expected to reach an estimated $17.2 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are high prevalence of chronic diseases, such as cancer, HIV, and diabetes and increasing investments in pharmaceutical research and development.

  • Lucintel forecasts that spectrophotometers is expected to witness the highest growth over the forecast period as it is affordable, easy to use, and are considered as an ideal choice for cell counting in a variety of settings, including hospitals, research laboratories, and food and beverage companies.
  • Within this market, hospitals will remain the largest segment due to easy accessibility, availability of advanced treatment facilities and efficient medical staff and growing numbers of patient pool.
  • APAC is expected to witness highest growth over the forecast period due to growing demand for toxicology testing products and precision medicines and increasing investments in research and development activities.

Emerging Trends in the Automated Cell Counters Market

The automated cell counter market is a host to various emerging trends that are not only reshaping the industry but have successfully become the driving force for innovation.

  • Integration of AI and Machine Learning: AI and machine learning are integrated into automated cell counters to improve accuracy and automate data analytics. This enables finer cell counting with improved handling of difficult samples.
  • Miniaturization of Devices: There is an increasing trend towards small and portable automated cell counters that occupy less space. Their usage can vary from small laboratories to field research.
  • High-Throughput Screening: High-throughput automated cell counters are in development to process volumes at higher speeds. This trend is of great importance, especially in large-volume research and clinical trials.
  • Imaging Techniques: High-resolution cameras and fluorescence microscopy are considered some of the new imaging technologies that improve the quality of cell counting. This allows for higher resolution and more accurate data.
  • Cost-Effective Solutions: With the interest in making available appropriate automated cell counters at low costs to small laboratories and research institutions, the market is reaching and being adopted more.

These trends are, in turn, changing the landscape of the Automated Cell Counter market by rapidly growing technology, accessibility, and analytics.

Recent Developments in the Automated Cell Counters Market

Recent developments within the Automated Cell Counter market have marked considerable advancement in technologies and applications.

  • AI Integration: The introduction of AI into automated cell counting has improved the accuracy in cell counting and the analysis of data. Such complex samples could also be handled better with AI algorithms, minimizing human errors.
  • Miniaturized Models: There have been new introductions in the automated cell counters of miniaturized models that boast portability and ease of use. Such models find their applications in smaller laboratories and in some mobile research applications.
  • High-throughput systems: Major high-throughput cell counters are in continuous development to allow large volumes of samples at very high speeds. These kinds of cell counters are also important in high-throughput clinical and research applications.
  • Imaging: Newer cell counters have built into them advanced microscopy, such as high resolution and fluorescence. These enhancements enable the analysis of cell samples with high detail and, at the same time, better visualization.
  • Affordable Solutions: The market is witnessing a surge in affordable automated cell counters. These affordable solutions can facilitate the availability of advanced cell counting technologies to a greater range of users.

These factors are contributing to the Automated Cell Counter market by positively impacting the capability, accessibility, and meeting the needs of a greater range of users.

Strategic Growth Opportunities for Automated Cell Counters Market

The Automated Cell Counter market has several strategic opportunities for growth in a few key applications:

  • Clinical Diagnostics: There is growing demand for efficient and effective cell counting in clinical diagnosis, hence giving way to the avenue of growth. Expansion in the range of products to fit the clinical field would increase the share in the market.
  • Research Laboratories: Growth in research activities pertaining to genomics and drug discovery opens up opportunities for high-throughput and advanced automated cell counters. Investment in such applications could, therefore, be drivers of market growth.
  • Point-of-Care Testing: The development of portable, user-friendly cell counters for point-of-care testing provides an increasing opportunity. These instruments meet the demand for remote and small-scale testing environments.
  • Regenerative Medicine: Demand for specialized automated cell counters opens up with the emergence of regenerative medicine and stem cell research. Targeting this niche would provide enormous growth potential.
  • Education and Training: This is another growing segment where automated cell counters are in demand due to various academic and training programs. Accessible and instructive models can now use this emerging segment to their advantage.

These emerging opportunities will continue to shape the Automated Cell Counter market through expanded applications, innovation, and new customer segments.

Automated Cell Counters Market Driver and Challenges

There are many drivers and challenges that shape the growth and development of the Automated Cell Counter market. The major ones are listed below:

The factors responsible for driving the automated cell counters market include:

1. Technological Advances: This extends to AI, imaging, and automation. Innovations in these areas enhance the accuracy and efficiency of cell counters, hence stirring the market. These advances come with the increasing demands of research and clinical applications.

2. Increasing Research and Clinical Demand: Growing demand for research and diagnostics encompasses increasing demand for accurate cell counting in research and diagnostics, hence propelling the growth of the market. It also calls for state-of-the-art, high-throughput cell counters for large-scale studies and diagnostic operations.

3. Expansion and Development of Healthcare and Research Infrastructure: The number of automated cell counters increases because of phenomenal infrastructural growth of healthcare and research institutions, especially in the emerging markets. This opens up new prospects in this market.

4. Growing Focus on Personalized Medicine: With greater emphasis on personalized medicine, accurate cell analysis and cell counting become increasingly required. It is here that automated cell counters play a significant role in the development and dispensing of personalized treatment methodologies.

5. Cost-cutting Measures: The manufacturing of cost-effective automated cell counters places new technologies within the reach of end-users who might otherwise not have been able to afford them, thereby stimulating growth across the market through the expansion of clientele.

Challenges in the automated cell counters market are:

1. High Initial Costs: The high prices of the advanced automated cell counters may hinder the diffusion due to their significant costs, which can be very unreachable for smaller laboratories and research institutions. Affordability needs to be addressed in order to widen the market further.

2. Regulatory Challenges: As new technologies could fall under different regulatory requirements, their navigation can usually be complex and time-consuming. Compliance with regulations is a must for market entry and product approval.

3. Market Competition: There is strong competition among the manufacturers that affects market share and price. To be competitive, companies need to innovate and differentiate their products.

These drivers and challenges are shaping the Automated Cell Counter market by influencing technological advancement, market dynamics, and regulatory compliance. Capitalizing on these growth opportunities and overcoming market obstacles depends on how these factors are effectively addressed.

List of Automated Cell Counters Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies automated cell counters companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the automated cell counters companies profiled in this report include-

  • Danaher
  • Thermo Fisher Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Sysmex Corporation
  • Beckman Coulter
  • HORIBA Medical
  • Mindray Medical International
  • Nihon Kohden
  • F. Hoffmann-La Roche

Automated Cell Counters by Segment

The study includes a forecast for the global automated cell counters by type, end use, and region.

Automated Cell Counter Market by Type [Analysis by Value from 2018 to 2030]:

  • Hematocytometers
  • Flow Cytometers
  • Electrical Impedance Coulter Counter
  • Spectrophotometers

Automated Cell Counter Market by End Use [Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Research Laboratories
  • Diagnostic Centers
  • Others

Automated Cell Counters Market by Region [Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Automated Cell Counters Market

The automated cell counter market is fast-developing, with advances that have only been possible due to changes in technology and greater precision over cells. In recent years, the United States, China, Germany, India, and Japan have reached out to innovations that should be pursued with regard to better accuracy, speed, and simplicity of cell counting technologies.

  • United States: With the increased surge being witnessed in the US market, advanced automated cell counters are coming equipped with AI and machine learning capabilities. Such technologies would further enhance the accuracy and efficiency of cell analysis, thus meeting high-level research and clinical needs.
  • China: China is seriously investing in the R&D and manufacturing of affordable automated cell counters. The focus is on making advanced cell-counting methodologies accessible to extended circles of laboratories and research institutions.
  • Germany: The country leads in the provision of high-throughput automation for cell counters. In addition, there are innovations in the form of advanced software related to data analysis and strong machinery capable of operating under huge volumes of samples within a clinical and research setup.
  • India: The market in India is seeing an increase in the installation of automated cell counters in diagnostic and research laboratories. Models that are cheaper and easy to operate are gaining traction, hence improving the accuracy of diagnosis and reducing pressure due to research work.
  • Japan: Japan is also doing its bit towards the growth of automated cell counters with precision-engineered models, featuring high-resolution images and real-time data analysis. Such development addresses both academic research and clinical diagnostics.

Features of the Global Automated Cell Counter Market

Market Size Estimates: Automated cell counters market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Automated cell counters market size by type, end use, and region in terms of value ($B).

Regional Analysis: Automated cell counters market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the automated cell counter market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the automated cell counter market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the automated cell counter market size?

Answer: The global automated cell counter market is expected to reach an estimated $17.2 billion by 2030.

Q2. What is the growth forecast for automated cell counter market?

Answer: The global automated cell counter market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the automated cell counter market?

Answer: The major drivers for this market are high prevalence of chronic diseases, such as cancer, HIV, and diabetes and increasing investments in pharmaceutical research and development.

Q4. What are the major segments for automated cell counter market?

Answer: The future of the global automated cell counter market looks promising with opportunities in the hospital, research laboratory, and diagnostic center markets.

Q5. Who are the key automated cell counter market companies?

Answer: Some of the key automated cell counters companies are as follows:

  • Danaher
  • Thermo Fisher Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Sysmex Corporation
  • Beckman Coulter
  • HORIBA Medical
  • Mindray Medical International
  • Nihon Kohden
  • F. Hoffmann-La Roche

Q6. Which automated cell counter market segment will be the largest in future?

Answer: Lucintel forecasts that spectrophotometers is expected to witness the highest growth over the forecast period as it is affordable, easy to use, and are considered as an ideal choice for cell counting in a variety of settings, including hospitals, research laboratories, and food and beverage companies.

Q7. In automated cell counter market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growing demand for toxicology testing products and precision medicines and increasing investments in research and development activities.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the automated cell counter market by type (hematocytometers, flow cytometers, electrical impedance coulter counter, and spectrophotometers), end use (hospitals, research laboratories, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
  • Market Report

Table of Contents

1. Executive Summary

2. Global Automated Cell Counter Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Automated Cell Counter Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Automated Cell Counter Market by Type
    • 3.3.1: Hematocytometers
    • 3.3.2: Flow Cytometers
    • 3.3.3: Electrical Impedance Coulter Counter
    • 3.3.4: Spectrophotometers
  • 3.4: Global Automated Cell Counter Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: Research Laboratories
    • 3.4.3: Diagnostic Centers
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Automated Cell Counter Market by Region
  • 4.2: North American Automated Cell Counter Market
    • 4.2.1: North American Automated Cell Counter Market by Type: Hematocytometers, Flow Cytometers, Electrical Impedance Coulter Counter, and Spectrophotometers
    • 4.2.2: North American Automated Cell Counter Market by End Use: Hospitals, Research Laboratories, Diagnostic Centers, and Others
  • 4.3: European Automated Cell Counter Market
    • 4.3.1: European Automated Cell Counter Market by Type: Hematocytometers, Flow Cytometers, Electrical Impedance Coulter Counter, and Spectrophotometers
    • 4.3.2: European Automated Cell Counter Market by End Use: Hospitals, Research Laboratories, Diagnostic Centers, and Others
  • 4.4: APAC Automated Cell Counter Market
    • 4.4.1: APAC Automated Cell Counter Market by Type: Hematocytometers, Flow Cytometers, Electrical Impedance Coulter Counter, and Spectrophotometers
    • 4.4.2: APAC Automated Cell Counter Market by End Use: Hospitals, Research Laboratories, Diagnostic Centers, and Others
  • 4.5: ROW Automated Cell Counter Market
    • 4.5.1: ROW Automated Cell Counter Market by Type: Hematocytometers, Flow Cytometers, Electrical Impedance Coulter Counter, and Spectrophotometers
    • 4.5.2: ROW Automated Cell Counter Market by End Use: Hospitals, Research Laboratories, Diagnostic Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Automated Cell Counter Market by Type
    • 6.1.2: Growth Opportunities for the Global Automated Cell Counter Market by End Use
    • 6.1.3: Growth Opportunities for the Global Automated Cell Counter Market by Region
  • 6.2: Emerging Trends in the Global Automated Cell Counter Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Automated Cell Counter Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Automated Cell Counter Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Danaher
  • 7.2: Thermo Fisher Scientific
  • 7.3: Merck KGaA
  • 7.4: Bio-Rad Laboratories
  • 7.5: Sysmex Corporation
  • 7.6: Beckman Coulter
  • 7.7: HORIBA Medical
  • 7.8: Mindray Medical International
  • 7.9: Nihon Kohden
  • 7.10: F. Hoffmann-La Roche